life science analytics framework version 9 4 (SAS institute)
SAS institute is a verified supplier 
93
Structured Review
SAS institute
life science analytics framework version 9 4
Life Science Analytics Framework Version 9 4, supplied by SAS institute, used in various techniques. Bioz Stars score: 93/100, based on 71 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/life+science+analytics+framework+version+9+4/SAS+Life+Science+Analytics+Framework/10__1016_slash_s1473___3099_ascii40_24_ascii41_00667___4-109-5-4
Average 93 stars, based on 71 article reviews
Life Science Analytics Framework Version 9 4, supplied by SAS institute, used in various techniques. Bioz Stars score: 93/100, based on 71 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/life+science+analytics+framework+version+9+4/SAS+Life+Science+Analytics+Framework/10__1016_slash_s1473___3099_ascii40_24_ascii41_00667___4-109-5-4
Average 93 stars, based on 71 article reviews
life science analytics framework version 9 4 - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
other:Article Title: A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study. Article Snippet: Statistical analyses were performed using SAS Article Title: Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial Article Snippet: Vaccine and Immunisation Research Group, Peter Doherty Institute and Murdoch Children’s Research Institute, Melbourne, VIC, Australia (Prof T Nolan PhD); GSK, Amsterdam, Netherlands (C Bhusal MD, A Willemsen MSc CStat); Vaccination and Travel Medicine Centre, Hradec Králové, Czechia (J Beran MD); Holdsworth House Medical Practice, Sydney, NSW, Australia (M Bloch); Kirby Institute, University of New South Wales, Sydney, NSW, Australia (M Bloch MBBS); Erciyes University, Faculty of Medicine, Kayseri, Türkiye (B S Cetin MD); Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Türkiye (E C Dinleyici MD); General Practice for Children and Adolescents, Jindřichův Hradec, Czechia (D Dražan MD); Tampereen yliopisto Oulun rokotetutkimusklinikka, Oulu, Finland (S Kokko MD); Tampereen yliopisto EteläHelsingin rokotetutkimusklinikka, Helsinki, Finland (S Koski MD); Tampereen yliopisto, Seinajoen rokotetutkimusklinikka, Seinajoki, Finland (O Laajalahti MD); Canadian Center for Vaccinology, Dalhousie University, IWK Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observerblinded trial |